Breaking News Instant updates and real-time market news.

PEP

PepsiCo

$107.78

-1.78 (-1.62%)

08:03
07/10/18
07/10
08:03
07/10/18
08:03

PepsiCo says cost inflation to pressure margins

Says continues to see 'pretty challenging conditions."

  • 10

    Jul

PEP PepsiCo
$107.78

-1.78 (-1.62%)

07/03/18
DBAB
07/03/18
DOWNGRADE
Target $116
DBAB
Hold
PepsiCo downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Stephen Powers downgraded PepsiCo to Hold with an unchanged price target of $116. The stock closed yesterday up 66c to $109.53. The analyst views the current valuation as a "bit bubbly." With at least 36 months of elevated investment, the stock's current risk/reward is fairly balanced, Powers tells investors in a research note.
07/03/18
07/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL), American Airlines (AAL), and Delta Airlines (DAL) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying in a world of "heightened" macroeconomic and geopolitical risks, economically-sensitive, high beta stocks such as airlines typically underperform the broader market. 2. Belmond (BEL) downgraded to Underweight from Overweight at Barclays with analyst Felicia Hendrix citing an analysis of the company's progress on its growth targets announced back in June 2016. 3. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank with analyst Jonathan Arnold saying The Federal Energy Regulatory Commission order raised new questions over New Jersey zero-emission credits. 4. PepsiCo (PEP) downgraded to Hold from Buy at Deutsche Bank with analyst Stephen Powers viewing the current valuation as a "bit bubbly." 5. Watsco (WSO), Fastenal (FAST), and Grainger (GWW) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he thinks the cycle and individual company results could remain solid for quarters or years to come, but he believes the cycle is in its later stages, thereby elevating risks to gross margins, rising labor costs, and earnings deceleration in 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/06/18
WELS
07/06/18
NO CHANGE
Target $107
WELS
Market Perform
Wells Fargo cautious on PepsiCo fundamentals into Q2 results
Wells Fargo analyst Bonnie Herzog is cautious on PepsiCo's fundamentals ahead of the company's Q2 earnings results on July 10. The analyst reduced her fiscal 2018 and 2019 estimates to reflect continued weakness in North American beverages, lower sales in Latin America following the May trucker strike in Brazil and incremental currency headwinds. However, despite these continued pressures, the market could react favorably to PepsiCo management providing more details on their ultimate plans for the Beverage business, Herzog tells investors in a pre-earnings research note titled "PEP: We're Not Feeling So Bubly About PEP's Q2 Fundamentals." The analyst keeps a Market Perform rating on PepsiCo with a $107 price target.
07/09/18
RBCM
07/09/18
NO CHANGE
Target $111
RBCM
Sector Perform
PepsiCo to remain constrained by troubled Beverage business, says RBC Capital
RBC Capital analyst Nik Modi previews Q2 results for PepsiCo, saying he expects the trends of troubled North America Beverage business and poor earnings quality that have been on display over the past few quarters to persist. Modi further warns that FX and cost increases will worsen in this quarter, while the operating environment becomes more uncertain because of the threat of trade wars. The analyst keeps his Sector Perform rating and $111 price target on PepsiCo.

TODAY'S FREE FLY STORIES

CJREF

Corus Entertainment

$0.00

(0.00%)

07:53
10/22/18
10/22
07:53
10/22/18
07:53
Upgrade
Corus Entertainment rating change  »

Corus Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTHM

Livent

$16.35

(0.00%)

07:53
10/22/18
10/22
07:53
10/22/18
07:53
Initiation
Livent initiated  »

Livent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRX

AcelRx

$3.62

-0.53 (-12.77%)

07:52
10/22/18
10/22
07:52
10/22/18
07:52
Recommendations
AcelRx analyst commentary  »

AcelRx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

EEM

iShares MSCI Emerging Markets ETF

$39.69

0.37 (0.94%)

07:52
10/22/18
10/22
07:52
10/22/18
07:52
Technical Analysis
iShares MSCI Emerging Markets ETF: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBBP

Strongbridge Biopharma

$4.87

-0.1 (-2.01%)

07:52
10/22/18
10/22
07:52
10/22/18
07:52
Hot Stocks
Strongbridge Biopharma presents results from Phase 3 SONICS study at ENEA »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

07:52
10/22/18
10/22
07:52
10/22/18
07:52
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UROV

Urovant Sciences

$11.62

-0.63 (-5.14%)

07:51
10/22/18
10/22
07:51
10/22/18
07:51
Initiation
Urovant Sciences initiated  »

Urovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$227.15

2.21 (0.98%)

07:50
10/22/18
10/22
07:50
10/22/18
07:50
Periodicals
Goldman says Trump regulators fall short in easing Volcker Rule, Bloomberg says »

Goldman Sachs is arguing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 26

    Oct

SHOO

Steven Madden

$28.09

-0.9 (-3.10%)

07:49
10/22/18
10/22
07:49
10/22/18
07:49
Recommendations
Steven Madden analyst commentary  »

Steven Madden price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

OZK

Bank OZK

$25.54

-9.31 (-26.71%)

07:47
10/22/18
10/22
07:47
10/22/18
07:47
Recommendations
Bank OZK analyst commentary  »

Bank OZK selloff likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MINI

Mobile Mini

$42.16

-1.21 (-2.79%)

07:46
10/22/18
10/22
07:46
10/22/18
07:46
Downgrade
Mobile Mini rating change  »

Mobile Mini downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

, CRM

Salesforce

$140.45

-2.44 (-1.71%)

07:45
10/22/18
10/22
07:45
10/22/18
07:45
Initiation
SurveyMonkey, Salesforce initiated  »

SurveyMonkey initiated…

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

CRM

Salesforce

$140.45

-2.44 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 03

    Mar

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

07:45
10/22/18
10/22
07:45
10/22/18
07:45
Initiation
SurveyMonkey initiated  »

SurveyMonkey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$28.73

-2.83 (-8.97%)

, PYPL

PayPal

$84.75

7.25 (9.35%)

07:44
10/22/18
10/22
07:44
10/22/18
07:44
Recommendations
eBay, PayPal analyst commentary  »

eBay could attract…

EBAY

eBay

$28.73

-2.83 (-8.97%)

PYPL

PayPal

$84.75

7.25 (9.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 03

    Mar

FLXN

Flexion

$18.96

0.33 (1.77%)

07:43
10/22/18
10/22
07:43
10/22/18
07:43
Hot Stocks
Flexion to present data from Phase 2 Zilretta study at ACR »

Flexion will present the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRI

Carter's

$94.38

-1.68 (-1.75%)

07:43
10/22/18
10/22
07:43
10/22/18
07:43
Recommendations
Carter's analyst commentary  »

Carter's price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

STRO

Sutro Biopharma

$14.55

0.03 (0.21%)

07:43
10/22/18
10/22
07:43
10/22/18
07:43
Initiation
Sutro Biopharma initiated  »

Sutro Biopharma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$28.73

-2.83 (-8.97%)

07:42
10/22/18
10/22
07:42
10/22/18
07:42
Downgrade
eBay rating change  »

eBay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 03

    Mar

HD

Home Depot

$179.87

-0.56 (-0.31%)

07:40
10/22/18
10/22
07:40
10/22/18
07:40
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

, MRK

Merck

$72.34

0.12 (0.17%)

07:39
10/22/18
10/22
07:39
10/22/18
07:39
Downgrade
Bristol-Myers, Merck rating change  »

Citi sees Merck showing…

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

MRK

Merck

$72.34

0.12 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 11

    Jan

  • 16

    Feb

  • 20

    May

XYL

Xylem

$69.26

-0.63 (-0.90%)

07:39
10/22/18
10/22
07:39
10/22/18
07:39
Recommendations
Xylem analyst commentary  »

Need better risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KMB

Kimberly-Clark

$110.30

0.79 (0.72%)

07:38
10/22/18
10/22
07:38
10/22/18
07:38
Hot Stocks
Kimberly-Clark sees FY18 share repurchases $800M »

Third quarter 2018 share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HOG

Harley-Davidson

$39.56

-0.81 (-2.01%)

07:38
10/22/18
10/22
07:38
10/22/18
07:38
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

EWBC

East West Bancorp

$53.86

0.1 (0.19%)

07:37
10/22/18
10/22
07:37
10/22/18
07:37
Upgrade
East West Bancorp rating change  »

East West Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 27

    Nov

  • 04

    Dec

STBZ

State Bank Financial

$25.44

-1.02 (-3.85%)

07:37
10/22/18
10/22
07:37
10/22/18
07:37
Earnings
State Bank Financial reports Q3 EPS 46c, consensus 57c »

Reports Q3 Tier 1 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.